We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreUsing Early Access Programs (EAPs) to give patients with life threatening conditions access to medic...
Read moreWe summarise the ISPOR Europe 2022 conference including plenary sessions on HTA, patient-centered re...
Read moreOur experts provide a detailed summary of Plenary Session 2 at ISPOR 2022 on innovative methods for ...
Read moreIntroduction Real World Data is being increasingly used across the globe to support medical-product ...
Read moreAccess to birth control is more important than ever after Roe v Wade was struck down, amid reports t...
Read moreNICE have been clear that this framework should not be interpreted as minimum standards for real-wor...
Read moreThrough the new fund, £340 million is to be made available to purchase promising, potentially life-...
Read moreThe drug was judged to offer an indication of major additional benefit in adult patients with advanc...
Read moreThe EHDS will integrate three main product markets for primary use of health data: electronic health...
Read more